1. Home
  2. YHC vs LIXT Comparison

YHC vs LIXT Comparison

Compare YHC & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YHC
  • LIXT
  • Stock Information
  • Founded
  • YHC 2021
  • LIXT 2005
  • Country
  • YHC United States
  • LIXT United States
  • Employees
  • YHC 4
  • LIXT N/A
  • Industry
  • YHC Beverages (Production/Distribution)
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • YHC Consumer Staples
  • LIXT Health Care
  • Exchange
  • YHC Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • YHC 1.9M
  • LIXT 2.2M
  • IPO Year
  • YHC N/A
  • LIXT N/A
  • Fundamental
  • Price
  • YHC $1.78
  • LIXT $4.11
  • Analyst Decision
  • YHC
  • LIXT
  • Analyst Count
  • YHC 0
  • LIXT 0
  • Target Price
  • YHC N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • YHC 7.4M
  • LIXT 6.3M
  • Earning Date
  • YHC 08-13-2025
  • LIXT 08-07-2025
  • Dividend Yield
  • YHC N/A
  • LIXT N/A
  • EPS Growth
  • YHC N/A
  • LIXT N/A
  • EPS
  • YHC N/A
  • LIXT N/A
  • Revenue
  • YHC $2,449,906.00
  • LIXT N/A
  • Revenue This Year
  • YHC $69.97
  • LIXT N/A
  • Revenue Next Year
  • YHC $403.29
  • LIXT N/A
  • P/E Ratio
  • YHC N/A
  • LIXT N/A
  • Revenue Growth
  • YHC 68.83
  • LIXT N/A
  • 52 Week Low
  • YHC $1.13
  • LIXT $0.64
  • 52 Week High
  • YHC $98.00
  • LIXT $4.48
  • Technical
  • Relative Strength Index (RSI)
  • YHC N/A
  • LIXT 66.85
  • Support Level
  • YHC N/A
  • LIXT $2.75
  • Resistance Level
  • YHC N/A
  • LIXT $4.48
  • Average True Range (ATR)
  • YHC 0.00
  • LIXT 0.68
  • MACD
  • YHC 0.00
  • LIXT 0.05
  • Stochastic Oscillator
  • YHC 0.00
  • LIXT 83.03

About YHC LQR House Inc. Common Stock

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: